{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:14:06Z","timestamp":1789391646389,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.neuropharm.2015.04.036","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T21:55:23Z","timestamp":1431640523000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Activation of angiotensin-(1\u20137)\/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats"],"prefix":"10.1016","volume":"97","author":[{"given":"Lucas M.","family":"Kangussu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila S.","family":"Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Nadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos B.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson A.S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Campagnole-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.04.036_bib1","doi-asserted-by":"crossref","first-page":"H1416","DOI":"10.1152\/ajpheart.00141.2007","article-title":"Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain","volume":"293","author":"Becker","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/01.HYP.26.6.1138","article-title":"Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7)","volume":"26","author":"Benter","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20110036","article-title":"Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors","volume":"121","author":"Bosnyak","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.HYP.30.3.549","article-title":"Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats","volume":"30","author":"Britto","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib5","first-page":"R89","article-title":"Differential baroreceptor reflex modulation by centrally infused angiotensin peptides","volume":"263","author":"Campagnole-Santos","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/01.HYP.31.1.362","article-title":"Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme","volume":"31","author":"Chappell","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/00004872-200018120-00019","article-title":"Modulation of the baroreflex control of heart rate by angiotensin-(1-7) at the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats","volume":"18","author":"Chaves","year":"2000","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib8","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.peptides.2010.06.030","article-title":"Altered cardiovascular reflexes responses in conscious angiotensin-(1-7) receptor Mas-knockout mice","volume":"31","author":"de Moura","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/FJC.0b013e3181734a54","article-title":"Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats","volume":"51","author":"Diz","year":"2008","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib10","first-page":"371","article-title":"Hypotensive function of the brain angiotensin-(1-7) in Sprague Dawley and renin transgenic rats","volume":"54","author":"Dobruch","year":"2003","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/CIRCRESAHA.109.208645","article-title":"Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension","volume":"106","author":"Feng","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1054-3589(10)59007-0","article-title":"Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7)","volume":"59","author":"Ferrario","year":"2010","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1369\/0022155411411712","article-title":"The angiotensin-(1-7)\/Mas receptor axis is expressed in sinoatrial node cells of rats","volume":"59","author":"Ferreira","year":"2011","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.HYP.38.3.665","article-title":"Angiotensin-(1-7): cardioprotective effect in myocardial ischemia\/reperfusion","volume":"38","author":"Ferreira","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib15","first-page":"589","article-title":"Selective increase of angiotensin(1-7) and its receptor in hearts of spontaneously hypertensive rats subjected to physical training","volume":"93","author":"Filho","year":"2008","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00441-012-1354-3","article-title":"Immunohistochemical localization of the angiotensin-(1-7) receptor Mas in the murine forebrain","volume":"348","author":"Freund","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FJC.0b013e3182588b32","article-title":"In\u00a0vivo expression of angiotensin-(1-7) lowers blood pressure and improves baroreflex function in transgenic (mRen2)27 rats","volume":"60","author":"Garcia-Espinosa","year":"2012","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/HYPERTENSIONAHA.111.173344","article-title":"Angiotensin (1-7) induces MAS receptor internalization","volume":"58","author":"Gironacci","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/01.HYP.0000143850.73831.9d","article-title":"Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats","volume":"44","author":"Gironacci","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib20","doi-asserted-by":"crossref","first-page":"H736","DOI":"10.1152\/ajpheart.00937.2006","article-title":"Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)","volume":"292","author":"Grobe","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib21","doi-asserted-by":"crossref","first-page":"H393","DOI":"10.1152\/ajpheart.00075.2012","article-title":"Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats","volume":"303","author":"Guimaraes","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib22","doi-asserted-by":"crossref","first-page":"IV6","DOI":"10.1002\/clc.4960141802","article-title":"Control of blood pressure by the renin-angiotensin-aldosterone system","volume":"14","author":"Hall","year":"1991","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib23","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.HYP.37.5.1309","article-title":"Baroreflex improvement in SHR after ace inhibition involves angiotensin-(1-7)","volume":"37","author":"Heringer-Walther","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2012.10.014","article-title":"Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats","volume":"67","author":"Jiang","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/HYPERTENSIONAHA.111.177600","article-title":"Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure","volume":"58","author":"Kar","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/eurheartj\/ehm048","article-title":"Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol","volume":"28","author":"Kasama","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0895-7061(95)00400-9","article-title":"The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects","volume":"9","author":"Langheinrich","year":"1996","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.CIR.0000105721.71640.DA","article-title":"Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats","volume":"109","author":"Li","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijcard.2009.07.015","article-title":"Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling","volume":"146","author":"Liu","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/344541a0","article-title":"Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene","volume":"344","author":"Mullins","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib32","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.HYP.27.6.1284","article-title":"Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats","volume":"27","author":"Oliveira","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0167-0115(95)00010-9","article-title":"Angiotensin-(1-7) binding at angiotensin II receptors in the rat brain","volume":"56","author":"Rowe","year":"1995","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCHEARTFAILURE.110.955013","article-title":"Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure","volume":"4","author":"Sabbah","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/HYPERTENSIONAHA.110.149815","article-title":"Lifetime overproduction of circulating angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling","volume":"55","author":"Santiago","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib36","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.113.01274","article-title":"Angiotensin-(1-7)","volume":"63","author":"Santos","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0361-9230(94)90104-X","article-title":"Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors","volume":"35","author":"Santos","year":"1994","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib38","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1517\/13543784.14.8.1019","article-title":"Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs","volume":"14","author":"Santos","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib39","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0196-9781(94)90051-5","article-title":"Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats","volume":"15","author":"Senanayake","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib40","doi-asserted-by":"crossref","first-page":"H2372","DOI":"10.1152\/ajpheart.00846.2011","article-title":"Angiotensin-(1-7) attenuates hypertension in exercise-trained renal hypertensive rats","volume":"302","author":"Shah","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1470320311402109","article-title":"Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1-7) in heart and kidney of spontaneously hypertensive rats","volume":"12","author":"Tan","year":"2011","journal-title":"J.\u00a0Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib42","doi-asserted-by":"crossref","first-page":"H2254","DOI":"10.1152\/ajpheart.00490.2007","article-title":"Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit","volume":"293","author":"Uemura","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2015.04.036_bib43","doi-asserted-by":"crossref","first-page":"e22682","DOI":"10.1371\/journal.pone.0022682","article-title":"ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function","volume":"6","author":"Xia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.04.036_bib44","doi-asserted-by":"crossref","first-page":"H699","DOI":"10.1152\/ajpheart.00193.2013","article-title":"Central endogenous angiotensin-(1-7) protects against aldosterone\/NaCl-induced hypertension in female rats","volume":"305","author":"Xue","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815001665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815001665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:46:44Z","timestamp":1758437204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815001665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":44,"alternative-id":["S0028390815001665"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.04.036","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of angiotensin-(1\u20137)\/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}